(Q41028153)

25 September 2017

title

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro (English)

1 reference

25 September 2017

D Latz

1

1 reference

25 September 2017

K Fleckenstein

2

1 reference

25 September 2017

M Eble

3

1 reference

25 September 2017

J Blatter

4

1 reference

25 September 2017

M Wannenmacher

5

1 reference

25 September 2017

K J Weber

6

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

International Journal of Radiation Oncology Biology Physics

25 September 2017

published in

1 reference

25 September 2017

volume

41

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

875-882

1 reference

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Increase in Radiosensitivity to Ionizing Radiation Related to Replacement of Thymidine in Mammalian Cells with 5-Bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

X-ray induction of chromatid exchanges in mitotic and G1 Chinese hamster cells pretreated with Colcemid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Mean inactivation dose: a useful concept for intercomparison of human cell survival curves

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Cellular Responses to Combinations of Hyperthermia and Radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

Repair of potentially lethal damage in x-irradiated HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

The role of DNA double strand breaks in lonizing radiation-induced killing of eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900105-9

7 January 2021

10.1016/S0360-3016(98)00105-9

Identifiers

DOI

1 reference

25 September 2017

1 reference